Houston-based Hatch Pitch will host two competitions in spring of 2020 — one marks the return of the competition to the Bayou City. Photo courtesy of Hatch Pitch

For eight years, Greg Wright has been organizing a SXSW pitch competition in Austin for startups from around the world that are using technology to improve life. In 2020, Wright is bringing Houston-based Hatch Pitch back into the Bayou City — a goal he's had for a while — for a new cybersecurity-focused event.

"Many people know us as being associated with Austin and SXSW, but not many people know us as being based in Houston," Wright tells InnovationMap. "There's been a big push to bring Hatch back to Houston, and what we've been struggling with is finding the right vehicle."

After Hatch Pitch Summit returns to Austin for its ninth year on March 16, Cyber Hatch will be hosted by the annual Houston Cyber Summit on April 28. Applications for both competitions are open and available online.

"We are excited to bring Hatch Pitch to Houston for the first time since 2013," says Wright, founder of the competition, in a press release. "The gathering of all this expertise at Houston Cyber Summit is the perfect place to foster innovation. It's an opportunity to meet and exchange ideas between startups, investors, customers, partners, leaders and change-makers."

The Houston Cyber Summit, which is going into its fourth year, will introduce a new innovation track to the event, which attracts cybersecurity experts from across industries. The pitch competition will shine a spotlight on early-stage companies creating safety and security online.

"The Houston Cyber Summit annually brings together a highly qualified, trusted network of business, government and academic leaders from across the Greater Houston region and beyond," says Umesh Verma, founder of Houston Cyber Summit and CEO of BLUE LANCE. "Partnering with industry leader Hatch Pitch, adds a new and exciting dimension to the cybersecurity and privacy landscape of our region and creates a new set of high paying jobs."

For each of the two spring competitions, four finalists will be selecting from hundreds of applications from companies around the world. All eight finalists will have access to mentors before pitching at the live events where they will field questions from the panel of judges. Similar to years prior, the pitches will be live streamed.

Over the past near decade, Hatch Pitch finalists have gone on to raise over $360 million and seen 11 successful exits. Recently Houston-based Braincheck, which won the competition in 2016, raised an $8M series A round earlier this year.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”